RSV、即ち呼吸器合胞体ウイルスは、上気道と下気道の両方で軽度の風邪のような症状を引き起こす一般的な呼吸器ウイルスです。RSVは、ほとんどの人が1、2週間で回復しますが、特に乳児や高齢者に有害な場合があります。クリーブランドクリニックによると、米国では毎年5歳未満の約57,000人の子供がRSVに感染しています。大規模な世界的な研究への取組みと数十年にわたるRSVの標的化にもかかわらず、依然として重大な医療ニーズが満たされていない状況にあります。将来の治療法については、これまで望ましい安全性プロフィールや有効性を証明することが困難になっています。数字がそれを物語っています。現在、成人向けのFDA承認のRSV薬はなく、リスクのある新生児向けのRSV薬は2つだけです。それでも、厳しいラベル付け、高価な価格設定、限られた抗ウイルス活性、毒性の懸念などの深刻な欠点があります。しかし、RSVワクチンの開発は過去10年間で大きな進歩を遂げました。RSVワクチンおよび抗体市場は、2024-2028年の間に38.90％のCAGRで成長すると予想されます。
複数のワクチンと抗体が最終段階の読み出しに近づいているため、2024年までにその一部の実用化と発売が実現する見込みです。推定は2024年から2028年までの期間について行われています。3つの主要な年齢層すべてを対象としたモダリティ（抗体とワクチン）の両方を考慮すると、世界のRSVワクチンと抗体の市場価値は2024年に25.6億ドル、2028年には95.3億ドルに増加すると予想されます。
目次
1. Executive Summary
2. Introduction
2.1 Respiratory Syncytial Virus (RSV) Vaccine & Antibody: An Overview
2.1.1 Antigenic Subtypes Of Respiratory Syncytial Virus
2.1.2 What Went Wrong With Previous RSV Vaccines?
2.1.3 Pre F Protein & It’s Increasing Use in RSV Vaccines
2.2 RSV Vaccine & Antibody (RSV) Segmentation: An Overview
2.2.1 Respiratory Syncytial Virus Vaccine & Antibody Segmentation
3. Global Market Analysis
3.1 Global RSV Vaccine And Antibody Market: An Analysis
3.1.1 Global RSV Vaccine And Antibody Market by Value
3.1.2 Global RSV Vaccine And Antibody Market by End User (Adult and Maternal and Pediatric)
3.1.3 Global RSV Vaccine And Antibody Market by Type (RSV Vaccine and RSV Antibody )
3.1.4 Global RSV Vaccine And Antibody Market by Region (The US, Europe, and ROW)
3.2 Global RSV Vaccine And Antibody Market: End User Analysis
3.2.1 Global Adult RSV Vaccine And Antibody Market by Value
3.2.2 Global Maternal & Pediatric RSV Vaccine And Antibody Market by Value
3.3 Global RSV Vaccine And Antibody Market: Type Analysis
3.3.1 Global RSV Vaccine Market by Value
3.3.2 Global RSV Vaccine Market by End User (Adult and Maternal and Pediatric)
3.3.3 Global RSV Vaccine Market by Region (The US, Europe, and ROW)
3.3.4 Global RSV Antibody Market by Value
3.3.5 Global RSV Antibody Market by Region (The US, Europe, and ROW)
3.4 Global RSV Vaccine Market: End User Analysis
3.4.1 Global Adult RSV Vaccine Market by Value
3.4.2 Global Maternal & Pediatric RSV Vaccine Market by Value
4. Regional Market Analysis
4.1 The US RSV Vaccine And Antibody Market: An Analysis
4.1.1 The US RSV Vaccine And Antibody Market by Value
4.1.2 The US RSV Vaccine Market by Value
4.1.3 The US RSV Vaccine Market by End User (Adult and Maternal and Pediatric)
4.1.4 The US Adult RSV Vaccine Market by Value
4.1.5 The US Adult RSV Vaccine Market by Product Type
4.1.6 The US Maternal & Pediatric RSV Vaccine Market by Value
4.1.7 The US Maternal & Pediatric RSV Vaccine Market by Product Type
4.1.8 The US RSV Antibody Market by Value
4.1.9 The US RSV Antibody Market by Product Type
4.2 Europe RSV Vaccine And Antibody Market: An Analysis
4.2.1 Europe RSV Vaccine And Antibody Market by Value
4.2.2 Europe RSV Vaccine Market by Value
4.2.3 Europe RSV Vaccine Market by End User (Adult and Maternal and Pediatric)
4.2.4 Europe Adult RSV Vaccine Market by Value
4.2.5 Europe Adult RSV Vaccine Market by Product Type
4.2.6 Europe Maternal & Pediatric RSV Vaccine Market by Value
4.2.7 Europe Maternal & Pediatric RSV Vaccine Market by Product Type
4.2.8 Europe RSV Antibody Market by Value
4.2.9 Europe RSV Antibody Market by Product Type
4.3 ROW RSV Vaccine And Antibody Market: An Analysis
4.3.1 ROW RSV Vaccine And Antibody Market by Value
4.3.2 ROW RSV Vaccine Market by Value
4.3.3 ROW RSV Vaccine Market by End User (Adult and Maternal and Pediatric)
4.3.4 ROW Adult RSV Vaccine Market by Value
4.3.5 ROW Adult RSV Vaccine Market by Product Type
4.3.6 ROW Maternal & Pediatric RSV Vaccine Market by Value
4.3.7 ROW Maternal & Pediatric RSV Vaccine Market by Product Type
4.3.8 ROW RSV Antibody Market by Value
4.3.9 ROW RSV Antibody Market by Product Type
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Healthcare
5.1.2 Impact of COVID-19 Restrictions on RSV Transmission
5.1.3 Impact of COVID-19 on RSV Vaccine and Antibody Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rapid Urbanization
6.1.2 Increasing Geriatric Population
6.1.3 Increasing Healthcare Expenditure
6.1.4 Rising Prevalence of Respiratory Syncytial Virus
6.1.5 Greater Unmet Need
6.1.6 Growing Instances of RSV Among Infants
6.1.7 Favorable Government Support
6.2 Challenges
6.2.1 High Cost of Vaccine Development
6.2.2 Inequitable Access to Vaccines
6.3 Market Trends
6.3.1 Use of Artificial Intelligence (AI) in Vaccine and Drug Design
6.3.2 Technological Advancements in Vaccine Administration
6.3.3 Competitive Pipeline
7. Competitive Landscape
7.1 Global RSV Vaccine And Antibody Market: Vaccine & Antibody Candidates
7.2 Global RSV Vaccine And Antibody Players By Market Share
7.3 Global RSV Vaccine And Antibody Market: Current Landscape
8. Company Profiles
8.1 Johnson & Johnson Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategies
8.2 Pfizer Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies
8.3 AstraZeneca Plc
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategies
8.4 GlaxoSmithKline
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategies
8.5 Merck & Co., Inc.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategies
8.6 Sanofi
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategies
8.7 Bavarian Nordic
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategies
8.8 Moderna Inc.
8.8.1 Business Overview
8.8.2 Business Strategies
8.9 Meissa Vaccines
8.9.1 Business Overview
8.9.2 Business Strategies
8.10 Advaccine
8.10.1 Business Overview
8.10.2 Business Strategies
8.11 Codagenix
8.11.1 Business Overview
8.11.2 Business Strategies
List of Figures
Figure 1: Antigenic Subtypes Of Respiratory Syncytial Virus
Figure 2: What went wrong with previous RSV vaccines?
Figure 3: Pre F Protein & It’s Increasing Use in RSV Vaccines
Figure 4: Respiratory Syncytial Virus Vaccine & Antibody Segmentation
Figure 5: Global RSV Vaccine And Antibody Market by Value; 2024-2028 (US$ Billion)
Figure 6: Global RSV Vaccine And Antibody Market by End User; 2024 & 2028 (Percentage, %)
Figure 7: Global RSV Vaccine And Antibody Market by Type; 2024 & 2028 (Percentage, %)
Figure 8: Global RSV Vaccine And Antibody Market by Region; 2024 (Percentage, %)
Figure 9: Global Adult RSV Vaccine And Antibody Market by Value; 2024-2028 (US$ Billion)
Figure 10: Global Maternal & Pediatric RSV Vaccine And Antibody Market by Value; 2024-2028 (US$ Billion)
Figure 11: Global RSV Vaccine Market by Value; 2024-2028 (US$ Billion)
Figure 12: Global RSV Vaccine Market by End User; 2024 (Percentage, %)
Figure 13: Global RSV Vaccine Market by Region; 2024 (Percentage, %)
Figure 14: Global RSV Antibody Market by Value; 2024-2028 (US$ Billion)
Figure 15: Global RSV Antibody Market by Region; 2024 (Percentage, %)
Figure 16: Global Adult RSV Vaccine Market by Value; 2024-2028 (US$ Billion)
Figure 17: Global Maternal & Pediatric RSV Vaccine Market by Value; 2024-2028 (US$ Million)
Figure 18: The US RSV Vaccine And Antibody Market by Value; 2024-2028 (US$ Billion)
Figure 19: The US RSV Vaccine Market by Value; 2024-2028 (US$ Billion)
Figure 20: The US RSV Vaccine Market by End User; 2024 (Percentage, %)
Figure 21: The US Adult RSV Vaccine Market by Value; 2024-2028 (US$ Billion)
Figure 22: The US Adult RSV Vaccine Market by Product Type; 2024-2028 (US$ Million)
Figure 23: The US Maternal & Pediatric RSV Vaccine Market by Value; 2024-2028 (US$ Million)
Figure 24: The US Maternal & Pediatric RSV Vaccine Market by Product Type; 2024-2028 (US$ Million)
Figure 25: The US RSV Antibody Market by Value; 2024-2028 (US$ Million)
Figure 26: The US RSV Antibody Market by Product Type; 2024-2028 (US$ Million)
Figure 27: Europe RSV Vaccine And Antibody Market by Value; 2024-2028 (US$ Billion)
Figure 28: Europe RSV Vaccine Market by Value; 2024-2028 (US$ Billion)
Figure 29: Europe RSV Vaccine Market by End User; 2024 (Percentage, %)
Figure 30: Europe Adult RSV Vaccine Market by Value; 2024-2028 (US$ Billion)
Figure 31: Europe Adult RSV Vaccine Market by Product Type; 2024-2028 (US$ Million)
Figure 32: Europe Maternal & Pediatric RSV Vaccine Market by Value; 2024-2028 (US$ Million)
Figure 33: Europe Maternal & Pediatric RSV Vaccine Market by Product Type; 2024-2028 (US$ Million)
Figure 34: Europe RSV Antibody Market by Value; 2024-2028 (US$ Million)
Figure 35: Europe RSV Antibody Market by Product Type; 2024-2028 (US$ Million)
Figure 36: ROW RSV Vaccine And Antibody Market by Value; 2024-2028 (US$ Billion)
Figure 37: ROW RSV Vaccine Market by Value; 2024-2028 (US$ Billion)
Figure 38: ROW RSV Vaccine Market by End User; 2024 (Percentage, %)
Figure 39: ROW Adult RSV Vaccine Market by Value; 2024-2028 (US$ Million)
Figure 40: ROW Adult RSV Vaccine Market by Product Type; 2024-2028 (US$ Million)
Figure 41: ROW Maternal & Pediatric RSV Vaccine Market by Value; 2024-2028 (US$ Million)
Figure 42: ROW Maternal & Pediatric RSV Vaccine Market by Product Type; 2024-2028 (US$ Million)
Figure 43: ROW RSV Antibody Market by Value; 2024-2028 (US$ Million)
Figure 44: ROW RSV Antibody Market by Product Type; 2024-2028 (US$ Million)
Figure 45: Global Urban Population as a Share of Total Population; 2014-2020 (Percentage, %)
Figure 46: Global Population by Age Group; 2016-2020 (Million)
Figure 47: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2021 (Percentage, %)
Figure 48: Global Market Size for Artificial Intelligence in Healthcare; 2016-2025 (US $Billion)
Figure 49: Johnson & Johnson Inc. Sales to Customers by Segments; 2021 (Percentage, %)
Figure 50: Pfizer Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 51: AstraZeneca Total Revenue by Disease Areas; 2021 (Percentage, %)
Figure 52: GlaxoSmithKline Turnover by Segments; 2021 (Percentage, %)
Figure 53: Merck & Co., Inc. Sales by Segments; 2021 (Percentage, %)
Figure 54: Sanofi Net Sales by Segments; 2021 (Percentage, %)
Figure 55: Bavarian Nordic Revenue by Products; 2021 (Percentage, %)
Table 1: RSV V/S COVID-19
Table 2: Global RSV Vaccine And Antibody Pipeline Snapshot
Table 3: Global RSV Vaccine And Antibody Players By Market Share
Table 4: Global RSV Vaccine And Antibody Market: Current Landscape
